The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company’s products are used to treat arterial blockages in the heart and legs and in the removal of pacemaker and defibrillator leads. The Company’s Vascular Intervention products include a range of laser catheters for ablation of blockages in arteries above and below the knee, the AngioSculpt scoring balloon used in both peripheral and coronary procedures and Stellarex drug-coated balloon peripheral angioplasty platform. The Company also markets support catheters and retrograde access and guidewire retrieval devices used in the treatment of peripheral arterial blockages. The Company markets aspiration and cardiac laser catheters to treat blockages in the heart. The Lead Management product line includes excimer laser sheaths, dilator sheaths, mechanical sheaths and accessories for the removal of pacemaker and defibrillator cardiac leads.
Show more
Type
Subsidiary
Parent Company
Philips
HQ
Colorado Springs, US
Founded
1984
The Spectranetics Corporation was founded in 1984 and is headquartered in Colorado Springs, US
Report incorrect company information

The Spectranetics Corporation Office Locations

The Spectranetics Corporation has offices in Paris, Würzburg, Leusden, Maple Grove and in 2 other locations
Colorado Springs, US (HQ)
9965 Federal Dr
Fremont, US
5055 Brandin Court
Fremont, US
6531 Dumbarton Circle
Maple Grove, US
6655 Wedgwood Road North
Paris, FR
18 rue de l’Arcade
Würzburg, DE
Schweinfurter Strasse 7
Show all (7)
Report incorrect company information

The Spectranetics Corporation Financials and Metrics

Summary Metrics

Founding Date

1984
The Spectranetics Corporation is a subsidiary of Philips

The Spectranetics Corporation Financials

The Spectranetics Corporation's revenue was reported to be $270.82 m in FY, 2016 which is a 10.1% increase from the previous period.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

158.8 m204.9 m246 m270.8 m

Revenue growth, %

29%20%10%

Cost of goods sold

41.4 m51.4 m62.9 m68.3 m

Gross profit

117.5 m153.5 m183.1 m202.5 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

39.8 m39.6 m43.6 m58.8 m57.4 m61.7 m61.7 m62.9 m67.7 m68.3 m69.7 m74.7 m

Cost of goods sold

10.1 m10.3 m10.5 m14.7 m14.8 m15.9 m15.8 m16.1 m17 m16.9 m18.1 m18.5 m

Gross profit

29.7 m29.3 m33 m44.1 m42.6 m45.8 m45.9 m46.8 m50.8 m51.4 m51.6 m56.2 m

Gross profit Margin, %

75%74%76%75%74%74%74%74%75%75%74%75%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

128.4 m95.5 m84.6 m57.2 m

Inventories

2.7 m8.1 m8.1 m27.6 m

Current Assets

167.8 m172.3 m158.3 m135.5 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

123.6 m120.9 m107 m103.5 m43.6 m49.3 m41.7 m67.5 m64.3 m58.9 m43.9 m57.5 m

Inventories

10 m9.8 m26 m26.5 m27.7 m27.8 m27.5 m26.3 m25.7 m26.7 m28.9 m29.6 m

Current Assets

161.3 m162.3 m175.7 m174.6 m121.5 m125.8 m117.2 m144 m139.2 m133.6 m123.3 m142.3 m

PP&E

26.6 m28.7 m30.5 m32.4 m38.3 m42.6 m45.1 m44.8 m44.6 m44.9 m45.5 m46.3 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(370 k)(40.9 m)(59.5 m)(58.1 m)

Depreciation and Amortization

10.6 m16.8 m26.6 m27.4 m

Inventories

(359 k)497 k497 k(3.7 m)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

434 k(5.7 m)(6.6 m)(13.9 m)(27.3 m)(7.2 m)(14.5 m)(17.3 m)(14.9 m)(13.3 m)(18.5 m)

Accounts Payable

4.6 m4.4 m4 m7.6 m9.5 m4.4 m5.3 m5.8 m6.6 m
Show all financial metrics
Report incorrect company information